PROGNOSTIC METHODOLOGY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150292021A1
SERIAL NO

14238763

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns a prognostic method for determining at least one, or a combination, of the following: time to first treatment, response to treatment or overall survival for a patient presenting with a disease including or characterised by telomere shortening, comprising an assessment of the longest mean telomere length at which telomere end-end fusion events can be detected and then a determination of the mean telomere length in the fusogenic range (i.e. the range below said mean telomere length at which telomere end-end fusion events can be detected) and the subsequent use of the mean telomere length in the fusogenic range as a prognostic indicator.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITEDWELSH SOUTH ENGLAND CARDIFF CARDIFF

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baird, Duncan Penarth, GB 5 7
Fegan, Christopher Cardiff, GB 4 5
Pepper, Chris Penarth, GB 11 211

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation